A carregar...
4CPS-098 Use of palivizumab in the immunoprofilaxis of respiratory syncytial virus
BACKGROUND: Palivizumab is a monoclonal antibody that provides passive immunity against respiratory syncytial virus (RSV). PURPOSE: To evaluate the use of palivizumab as immunoprophylaxis against RSV in the 2016 to 2017 campaign in a tertiary hospital. MATERIAL AND METHODS: Retrospective observation...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535401/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.189 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|